NCT06490055View on ClinicalTrials.gov

Predicting the Efficacy in Advanced Gastric Cancer.

CompletedOBSERVATIONAL
Enrollment

162

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

February 18, 2025

Study Completion Date

July 1, 2025

Conditions
Gastric CancerChemotherapy EffectPaclitaxelRamucirumab
Interventions
DRUG

Paclitaxel

Gastric cancer second-line Chemotherapy (paclitaxel plus ramucirumab)

Trial Locations (2)

91016

Department of Molecular Diagnostics and Experimental Therapeutics, Monrovia

7010192

Kawasaki Medical University, Kurashiki

All Listed Sponsors
lead

City of Hope Medical Center

OTHER

NCT06490055 - Predicting the Efficacy in Advanced Gastric Cancer. | Biotech Hunter | Biotech Hunter